Evidence map›Paper›PMID 37946490›Full record

ArticleJournal of traditional Chinese medicine = Chung i tsa chih ying wen pan2023

Efficiency and safety of acupuncture for women with premature ovarian insufficiency: study protocol for a randomized controlled trial.

X U Yani, Zhang Yutong, H E Weile, Dai Linglin, Tang Ding, Wang Jialing, Zhang Xufen, Chen Qin, Chen Lifang, Wang Zhanglian and 1 more

Open access · greenAbstract readClinical Trial Protocol
In one paragraph

Article in Journal of traditional Chinese medicine = Chung i tsa chih ying wen pan, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

X U Yanithe Third School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou 310053, China.
Zhang Yutongthe Third School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou 310053, China.
H E Weilethe Third School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou 310053, China.
Dai Linglinthe Third School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou 310053, China.
Tang Dingthe Third School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou 310053, China.
Wang Jialingthe Third School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou 310053, China.
Zhang Xufenthe Third School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou 310053, China.
Chen QinDepartment of Acupuncture, the Third Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou 310005, China.
Chen LifangDepartment of Acupuncture, the Third Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou 310005, China.
Wang ZhanglianDepartment of Acupuncture, the Third Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou 310005, China.
Zhan MingjieDepartment of Acupuncture, the Third Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou 310005, China.
Zhejiang Chinese Medical University · CNThe Third Affiliated Hospital of Zhejiang Chinese Medical University · CN

Funding

Administration of Traditional Chinese Medicine of Zhejiang Province 2021ZB145Inheritance Studio Construction Project of National Famous Old Chinese Medicine Experts of Dr. Wang Zhanglian [Letter of the Department of Personnel and Education of the National Administration of Traditional Chinese Medicine( 2022) 75
6 · The paper itself

Abstract

Acupuncture has been widely used as an alternative and complementary therapy for premature ovarian insufficiency (POI) in China. However, research to date has not shown that acupuncture is effective for POI compared with hormone replacement therapy (HRT). We will conduct a randomized, controlled, and outcome assessor-blind trial to evaluate the efficacy and safety of acupuncture on POI. Seventy-six patients with POI will be randomly assigned to two groups. The treatment group will receive twenty-eight one-hour sessions of acupuncture treatments, and the control group will receive 12-week HRT. The whole study will consist of a 12-week treatment plan and a 12-week follow-up session. The primary outcome is measured by changes in serum anti-Müllerian hormone and follicle-stimulating hormone (FSH) levels at weeks 12 and 24. Secondary outcome measures include estradiol, luteinizing hormone (LH), LH/FSH ratio, Kupperman index, and menstrual condition. This trial is expected to clarify whether or not acupuncture is effective and safe for POI compared with HRT.

Indexed as

Acupuncture TherapyPrimary Ovarian InsufficiencyEstradiolFemaleFollicle Stimulating HormoneHumansLuteinizing HormoneRandomized Controlled Trials as TopicEstradiolFollicle Stimulating HormoneLuteinizing Hormoneacupuncturehormone replacement therapyprimary ovarian insufficiencyrandomized controlled trialstudy protocols

Identifiers

PMID37946490
PMCPMC10623257
OpenAlexW4388578128

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.